Search

Search Constraints

You searched for: Author/Creator Topp, Max S.

Search Results

1. Blinatumomab treatment of older adults with relapsed/refractory B‐precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies. Issue 14 (3rd May 2016)

3. Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia. Issue 9 (29th July 2019)

4. Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis. (18th March 2021)

5. Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia. Issue 11 (18th September 2020)

6. Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma. (29th September 2021)

7. Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab. Issue 4 (3rd November 2020)

8. Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Issue 4 (24th March 2022)

9. Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study. Issue 23 (21st August 2019)

10. Virus variant–specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022. (February 2023)